網頁2024年2月18日 · Funding will further accelerate commercialization of the Steripath® Initial Specimen Diversion Device® platform and fast-track new innovations in sepsis diagnostic accuracy and timeliness. Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indi 網頁2024年1月19日 · Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the Central Texas VA Health Care System in Temple, TX, published their findings comparing results of two devices: Kurin and Steripath® (Magnolia Medical Technologies, Inc.) in the online edition of the Journal of Emergency …
BD, Magnolia Medical to jointly commercialise Steripath devices
網頁2024年8月1日 · Magnolia Medical Technologies has won the patent-infringement lawsuit against Kurin regarding the illegal use of its Initial Specimen Diversion Device (ISDD) technology. A jury for the U.S. District Court of Delaware delivered two unanimous decisions in Magnolia Medical Technologies’ favour. Following a two-phased trial and brief ... 網頁2024年1月10日 · Magnolia Medical Technologies, Inc. ("Magnolia Medical"), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) family of products, today announced the publication of ... fedex office print \u0026 ship center st louis mo
Challenging the Status Quo for Improved Patient Outcomes
網頁2024年9月13日 · Magnolia Medical Technologies, Inc. ("Magnolia Medical"), inventors of the Steripath® Initial Specimen Diversion Device® (ISDD®) family of products, today announced it filed a motion for permanent injunction in the U.S. District Court for the District of Delaware on September 9, 2024, that would prohibit Kurin, Inc. ("Kurin") from the … 網頁Results: There was an 82.8% reduction in false positives with the unique specimen collection system compared with the standard method (chi-squared test with Yates correction, 2-tailed, P = 0.0001). Based on the historical 3.52% rate of blood-culture contamination for our health facilities, 2.92 false positives were prevented for every 100 blood ... 網頁K200661 510(k) Summary In accordance with 21 CFR 807.92(c) the following summary information is provided: 510(k) Number: K200661 Date Prepared: September 10, 2024 … deepwoken vow of mastery requirements